Andaris founder sets up contrast agent company
This article was originally published in Clinica
Executive Summary
One of the founders of Andaris, a UK ultrasound imaging company which was sold to Quadrant Healthcare, is setting up a new company to develop novel contrast agents based on microcapsule and nanosphere technology. Richard Johnson is launching Upperton as a "virtual company", based around the R&D facilities of Nottingham University. He is looking to offer collaborative research to other companies as well as to develop Upperton's own products.